Moderators | @NEJM Ask the Authors & Experts: Nivolumab versus... | NEJM Resident 360

@NEJM Ask the Authors & Experts: Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma & Targeting an Immune Checkpoint or Multiple Kinases

Q&A has ended

Authors
Robert Motzer, MD

Attending Physician at Memorial Sloan-Kettering Cancer Center

Robert Motzer, MD

Robert Motzer, MD

Attending Physician at Memorial Sloan-Kettering Cancer Center

Attending Physician at Memorial Sloan-Kettering Cancer Center
Bernard Escudier, MD

Lead, Immunotherapy Unit at Gustave Roussy Institute

Bernard Escudier, MD

Bernard Escudier, MD

Lead, Immunotherapy Unit at Gustave Roussy Institute

Lead, Immunotherapy Unit at Gustave Roussy Institute
David McDermott, MD

Leader, Kidney Cancer Program, Dana-Farber/Harvard Cancer Center, Director/Attending Biologic Therapy and Cutaneous Oncology Programs, Hematology/Oncology, Beth Israel Deaconess Medical Center

David McDermott, MD

David McDermott, MD

Leader, Kidney Cancer Program, Dana-Farber/Harvard Cancer Center, Director/Attending Biologic Therapy and Cutaneous Oncology Programs, Hematology/Oncology, Beth Israel Deaconess Medical Center

Leader, Kidney Cancer Program, Dana-Farber/Harvard Cancer Center, Director/Attending Biologic Therapy and Cutaneous Oncology Programs, Hematology/Oncology, Beth Israel Deaconess Medical Center
Saby George, MD, FACP

Assistant Professor of Oncology at Roswell Park Cancer Institute

Saby George, MD, FACP

Saby George, MD, FACP

Assistant Professor of Oncology at Roswell Park Cancer Institute

Assistant Professor of Oncology at Roswell Park Cancer Institute
Hans Hammers, MD, PhD

Assistant Professor of Oncology at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Hans Hammers, MD, PhD

Hans Hammers, MD, PhD

Assistant Professor of Oncology at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Assistant Professor of Oncology at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
John Wagstaff, MD, MB, ChB, FRCP

Professor of Medical Oncology at Swansea University

John Wagstaff, MD, MB, ChB, FRCP

John Wagstaff, MD, MB, ChB, FRCP

Professor of Medical Oncology at Swansea University

Professor of Medical Oncology at Swansea University
Primo Lara, MD

Associate Director for Translational Research at UC Davis Comprehensive Cancer Center

Primo Lara, MD

Primo Lara, MD

Associate Director for Translational Research at UC Davis Comprehensive Cancer Center

Associate Director for Translational Research at UC Davis Comprehensive Cancer Center
Toni Choueiri, MD

Director of The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute

Toni Choueiri, MD

Toni Choueiri, MD

Director of The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute

Director of The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
David Quinn, MBBS (Hons. I) PhD FRACP FACP

Head, Section of Genitourinary Medical Oncology at Keck School of Medicine, University of Southern California

David Quinn, MBBS (Hons. I) PhD FRACP FACP

David Quinn, MBBS (Hons. I) PhD FRACP FACP

Head, Section of Genitourinary Medical Oncology at Keck School of Medicine, University of Southern California

Head, Section of Genitourinary Medical Oncology at Keck School of Medicine, University of Southern California

Experts
Thomas Hutson, DO, PharmD, FACP

Urologic Medical Oncologist

Thomas Hutson, DO, PharmD, FACP

Thomas Hutson, DO, PharmD, FACP

Urologic Medical Oncologist

Urologic Medical Oncologist
Emiliano Calvo, MD, PhD

Director of Clinical Research at START Madrid-Centro Integral Oncológico Clara Campal

Emiliano Calvo, MD, PhD

Emiliano Calvo, MD, PhD

Director of Clinical Research at START Madrid-Centro Integral Oncológico Clara Campal

Director of Clinical Research at START Madrid-Centro Integral Oncológico Clara Campal
Stephane Oudard, MD, PhD

Professor of Oncology and Chief of the Oncology Clinical and Translational Research Unit at Georges Pompidou Hospital

Stephane Oudard, MD, PhD

Stephane Oudard, MD, PhD

Professor of Oncology and Chief of the Oncology Clinical and Translational Research Unit at Georges Pompidou Hospital

Professor of Oncology and Chief of the Oncology Clinical and Translational Research Unit at Georges Pompidou Hospital
Roberto Iacovelli, MD

Oncologist at European Institute of Oncology in Milan

Roberto Iacovelli, MD

Roberto Iacovelli, MD

Oncologist at European Institute of Oncology in Milan

Oncologist at European Institute of Oncology in Milan
Go Kimura, MD, PhD

Associate Professor, Dept of Urology at Nippon Medical School

Go Kimura, MD, PhD

Go Kimura, MD, PhD

Associate Professor, Dept of Urology at Nippon Medical School

Associate Professor, Dept of Urology at Nippon Medical School
Charles Drake, MD, PhD

Professor of Oncology at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Charles Drake, MD, PhD

Charles Drake, MD, PhD

Professor of Oncology at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Professor of Oncology at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Tim Eisen, MD, PhD

Professor of Medical Oncology at Cambridge University Hospitals NHS Foundation Trust

Tim Eisen, MD, PhD

Tim Eisen, MD, PhD

Professor of Medical Oncology at Cambridge University Hospitals NHS Foundation Trust

Professor of Medical Oncology at Cambridge University Hospitals NHS Foundation Trust

Lead Moderators
Nick Liu, MD

Urologic Oncology Fellow at Memorial Sloan-Kettering Cancer Center

Nick Liu, MD

Nick Liu, MD

Urologic Oncology Fellow at Memorial Sloan-Kettering Cancer Center

Urologic Oncology Fellow at Memorial Sloan-Kettering Cancer Center

Moderators
Renae Shibata

Medical Student at Oakland University William Beaumont School of Medicine

Renae Shibata

Renae Shibata

Medical Student at Oakland University William Beaumont School of Medicine

Medical Student at Oakland University William Beaumont School of Medicine

Moderators

Renae Shibata
View Profile
Renae Shibata is currently starting her 3rd year in medical school at the Oakland University William Beaumont School of Medicine. She graduated from the University of California, San Diego with a BS in Neuroscience and Physiology in 2012. Before entering medical school she was an after school program coordinator for AmeriCorps at MS118 in the Bronx, New York where she developed a science and leadership curriculum.